Abstract:Background Accumulating experimental evidence suggests that the microbiome plays an important role in cancer metastasis; however, microbial features of human colorectal cancer (CRC) metastases remain largely unknown. Here, we performed an integrated metagenomic and metabolomic analysis of primary CRC and its associated liver metastases. Methods CRC patients (N=98) who underwent the resection of primary lesions and developed liver metastases were included. Metagenomic and metabolomic analysis was performed on paired CRC tumors, paracancerous normal colon (adj-CRC), liver metastases (LM), and paracancerous normal liver (adj-LM) to profile alteration in the gut microbiome and metabolites by DESeq2. Results Distinct microbiome profiles are observed in paired CRC tumor, adj-CRC, paired LM and adj-LM tissues. Colonic microbiota was dominated by the phyla Firmicutes and Bacteroidetes, whereas Proteobacteria was most abundant in the liver. LM and adj-LM were further separated into two distinct clusters, with significant enrichments of Bacteroides and Fusobacteria in LM compared to adj-LM (P<0.05). Within the Taxonomy >20% prevalence in CRC, the dysregulated proportion of Firmicutes, Actinobacteria and Fusobacteria was found in LM compared to adj-LM. In terms of metabolomic profiling, amino acids metabolism and energy production were dysregulated in LM. Integrative analyses revealed that many microbial-metabolite connections showed a similar trend among CRC and LM tissues. Notably, the abundance of Ruminococcus, Christensenellaceae, Fretibacterium, Ruminococcaceae, and Intestinimonas was significantly higher in CRC patients with post-operative recurrence compared to the patients with no recurrence. These microbes were also associated with patient poor survival. Besides, we identified 12-hydroxy-12-octadecanoylcarnitine and 3-hydroxy-9Z-octadecenoyl-carnitine as metabolites that were concomitantly enriched in both primary CRC and recurrent LM. These microbial and metabolite biomarkers, respectively, predict patient survival and recurrence of LM in CRC. Conclusions We identified the microbiome and metabolic signatures in primary CRC that are associated with LM, which may play an important role in driving liver metastases.

In-Depth Characterization of Mass Spectrometry-Based Proteomic Profiles Revealed Novel Signature Proteins Associated with Liver Metastatic Colorectal Cancers

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

Evaluation of Hepatic-Metastasis Risk of Colorectal Cancer Upon the Protein Signature of Pi3k/Akt Pathway

Large scale systematic proteomic quantification from non-metastatic to metastatic colorectal cancer

Proteomic analysis of two metabolic proteins with potential to translocate to plasma membrane associated with tumor metastasis development and drug targets.

[Application of SELDI-TOF-MS in Detection of Liver Metastasis from Colorectal Cancer].

A Research Study of the Serum Proteomics Expressions on Liver Metastases Value in Colorectal Carcinoma

Co-expression Network Analysis Identified Key Proteins in Association with Hepatic Metastatic Colorectal Cancer

Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer

Study on Proteomics in Hepatic Metastasis of Colorectal neoplasms

Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes

In-depth analysis of lymph node metastasis-related sialylated protein profiling and their clinical and biological significance in colorectal cancer using mass spectrometry and multi-omics technologies

Comprehensive Profiling of Metastasis-Related Proteins in Paired Hepatocellular Carcinoma Cells with Different Metastasis Potentials

IDDF2023-ABS-0250 Comprehensive Analyses of Microbiome and Metabolism Reveal Liver Metastasis-Specific Signature in Colorectal Cancer

Spatial Proteomic Profiling of Colorectal Cancer Revealed Its Tumor Microenvironment Heterogeneity

Proteomic Study on Multi-Organ Metastases of Human Ovarian Clear Cell Carcinoma Cell Line in a Xenograft Mouse Model Based on a Novel Sequence-Specific Analysis Strategy

Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases

Quantitative proteome analysis of tumor markers associated with colorectal cancer

Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.